Controlled Human Infection for Vaccination Against Streptococcus Pyogenes (CHIVAS)
Group A Streptococcal Human Challenge Study: Building a Pharyngitis Model to Accelerate Vaccine Development
Sponsor: Andrew Steer
Listed as NCT03361163, this PHASE1 trial focuses on Bacterial Infections and Gram-Positive Bacterial Infections and remains completed. Sponsored by Andrew Steer, it has been updated 12 times since 2018, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Mar 2023 — Jul 2024 [monthly]
Completed PHASE1
-
Jan 2021 — Mar 2023 [monthly]
Completed PHASE1
-
Jun 2020 — Jan 2021 [monthly]
Completed PHASE1
Status: Active Not Recruiting → Completed
▶ Show 7 earlier versions
-
Jan 2020 — Jun 2020 [monthly]
Active Not Recruiting PHASE1
Status: Recruiting → Active Not Recruiting
-
Sep 2019 — Jan 2020 [monthly]
Recruiting PHASE1
-
Jun 2019 — Sep 2019 [monthly]
Recruiting PHASE1
-
Apr 2019 — Jun 2019 [monthly]
Recruiting PHASE1
-
Jul 2018 — Apr 2019 [monthly]
Recruiting PHASE1
Status: Not Yet Recruiting → Recruiting
-
Jun 2018 — Jul 2018 [monthly]
Not Yet Recruiting PHASE1
-
Dec 2017 — Jun 2018 [monthly]
Not Yet Recruiting PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Andrew Steer
- Griffith University
- National Health and Medical Research Council, Australia
- Nucleus Network Ltd
- Queen Fabiola Children's University Hospital
- Telethon Kids Institute
- The Peter Doherty Institute for Infection and Immunity
- The University of Queensland
- University of Auckland, New Zealand
- University of Melbourne
- University of Tennessee
- University of Wollongong
For direct contact, visit the study record on ClinicalTrials.gov .